Combined Oral Supplementation of Fish Oil and Quercetin Enhances Neuroprotection in a Chronic Rotenone Rat Model: Relevance to Parkinson’s Disease

Neurochemical Research

Volumn 40, Issue 5, 2015, Pages 894-905

  Denny Joseph, K M ^a   Muralidhara, ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Behavioral impairments; Brain; Fish oil; Oxidative stress; Parkinson s disease; Quercetin; Rotenone

Indexed keywords

FISH OIL; NEUROPROTECTIVE AGENT; QUERCETIN; ROTENONE;

ANIMAL; COMBINATION DRUG THERAPY; DISEASE MODEL; DRUG EFFECTS; HAND STRENGTH; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PARKINSON DISEASE; PHYSIOLOGY; RAT; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FISH OILS; HAND STRENGTH; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; QUERCETIN; RATS; RATS, WISTAR; ROTENONE;

EID: 84939962765     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1542-0     Document Type: Article

References (45)

1. Shinto L, Quinn J, Montine T et al (2014) A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. J Alzheimers Dis 38:111–120. doi:10.3233/JAD-130722
2. Flores-Mancilla LE, Hernandez-Gonzalez M, Guevara MA et al (2014) Long-term fish oil supplementation attenuates seizure activity in the amygdala induced by 3-mercaptopropionic acid in adult male rats. Epilepsy Behav 33:126–134. doi:10.1016/j.yebeh.2014.02.023
3. Bousquet M, Saint-Pierre M, Julien C et al (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease. FASEB J 22:1213–1225. doi:10.1096/fj.07-9677com
4. 1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 62:184–191. doi:10.1016/j.neuropharm.2011.06.017
5. Giunta B, Hou H, Zhu Y et al (2010) Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice. Neurosci Lett 471:134–138. doi:10.1016/j.neulet.2010.01.026
6. Pan Y, Araujo JA, Burrows J et al (2013) Cognitive enhancement in middle-aged and old cats with dietary supplementation with a nutrient blend containing fish oil, B vitamins, antioxidants and arginine. Br J Nutr 110:40–49. doi:10.1017/S0007114512004771
7. Denny Joseph KM, Muralidhara (2013) Enhanced neuroprotective effect of fish oil in combination with quercetin against 3-nitropropionic acid induced oxidative stress in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 40:83–92. doi:10.1016/j.pnpbp.2012.08.018
8. Dajas F (2012) Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol 143:383–396. doi:10.1016/j.jep.2012.07.005
9. Manjunath MJ, Muralidhara (2013) Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brain. Cent Nerv Syst Agents Med Chem 13:43–56
10. Manjunath MJ, Muralidhara (2013) Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster. J Food Sci Technol. doi:10.1007/s13197-013-1219-0
11. Tanner CM, Kamel F, Ross GW et al (2011) Rotenone, paraquat, and Parkinson’s disease. Environ Health Perspect 119:866–872. doi:10.1289/ehp.1002839
12. Denny Joseph KM, Muralidhara (2012) Fish oil prophylaxis attenuates rotenone-induced oxidative impairments and mitochondrial dysfunctions in rat brain. Food Chem Toxicol 50:1529–1537. doi:10.1016/j.fct.2012.01.020
13. Camargo CA, da Silva MEF, da Silva RA et al (2011) Inhibition of tumor growth by quercetin with increase of survival and prevention of cachexia in Walker 256 tumor-bearing rats. Biochem Biophys Res Commun 406:638–642. doi:10.1016/j.bbrc.2011.02.111
14. Al Mutairy A, Al Kadasah S, Elfaki I et al (2010) Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicol Teratol 32:226–233. doi:10.1016/j.ntt.2009.09.003
15. Prasad SN, Muralidhara (2013) Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence. Neurochem Res 38:330–345. doi:10.1007/s11064-012-0924-9
16. Moreadith RW, Fiskum G (1984) Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal Biochem 137:360–367
17. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
18. Driver AS, Kodavanti PR, Mundy WR (2000) Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 22:175–181. doi:10.1016/S0892-0362(99)00069-0
19. Wolff SP (1994) Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth Enzymol 233C:182–189. doi:10.1016/S0076-6879(94)33021-2
20. Mokrasch LC, Teschke EJ (1984) Glutathione content of cultured cells and rodent brain regions: a specific fluorometric assay. Anal Biochem 140:506–509
21. Kostyuk VA, Potapovich AI (1989) Superoxide–driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem Int 19:1117–1124
22. Aebi H (1984) Catalase in vitro. Meth Enzymol 105:121–126
23. Luthman M, Holmgren A (1982) Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry 21:6628–6633
24. Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. Meth Enzymol 105:114–121
25. Guthenberg C, Alin P, Mannervik B (1985) Glutathione transferase from rat testis. Meth Enzymol 113:507–510
26. Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
27. Dalpiaz A, Filosa R, de Caprariis P et al (2007) Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 336:133–139. doi:10.1016/j.ijpharm.2006.11.051
28. Pennington RJ (1961) Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J 80:649–654
29. Navarro A, Gomez C, López-Cepero JM, Boveris A (2004) Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol Regul Integr Comp Physiol 286:R505–R511. doi:10.1152/ajpregu.00208.2003
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
31. Heinrichs SC (2010) Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function. Mol Nutr Food Res 54:447–456. doi:10.1002/mnfr.200900201
32. Delattre AM, Kiss A, Szawka RE et al (2010) Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson’s disease. Neurosci Res 66:256–264. doi:10.1016/j.neures.2009.11.006
33. Chen H-W, Tsai C-W, Yang J-J et al (2003) The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats. Br J Nutr 89:189–200. doi:10.1079/BJN2002766
34. Dubey P, Jayasooriya AP, Cheema SK (2012) Fish oil induced hyperlipidemia and oxidative stress in BioF1B hamsters is attenuated by elderberry extract. Appl Physiol Nutr Metab 37:472–479. doi:10.1139/h2012-030
35. Sanchez-Reus MI, Gómez del Rio MA, Iglesias I et al (2007) Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats. Neuropharmacology 52:606–616. doi:10.1016/j.neuropharm.2006.09.003
36. Venkateshappa C, Harish G, Mythri RB et al (2012) Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson’s disease. Neurochem Res 37:358–369. doi:10.1007/s11064-011-0619-7
37. Smeyne M, Smeyne RJ (2013) Glutathione metabolism and Parkinson’s disease. Free Radic Biol Med 62:13–25. doi:10.1016/j.freeradbiomed.2013.05.001
38. 10. Free Radic Biol Med 50:1053–1064. doi:10.1016/j.freeradbiomed.2011.02.004
39. Chiou TJ, Tzeng WF (2000) The roles of glutathione and antioxidant enzymes in menadione-induced oxidative stress. Toxicology 154:75–84
40. Schmatz R, Mazzanti CM, Spanevello R et al (2009) Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 610:42–48. doi:10.1016/j.ejphar.2009.03.032
41. Rosengarten B, Paulsen S, Burr O, Kaps M (2009) Neurovascular coupling in Alzheimer patients: effect of acetylcholine-esterase inhibitors. Neurobiol Aging 30:1918–1923. doi:10.1016/j.neurobiolaging.2008.02.017
42. Xiong N, Long X, Xiong J et al (2012) Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models. Crit Rev Toxicol 42:613–632. doi:10.3109/10408444.2012.680431
43. Costa C, Belcastro V, Tozzi A et al (2008) Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J Neurosci 28:8040–8052. doi:10.1523/JNEUROSCI.1947-08.2008
44. Coppey LJ, Holmes A, Davidson EP, Yorek MA (2012) Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat. J Nutr Metab 2012:950517. doi:10.1155/2012/950517
45. Kaur H, Chauhan S, Sandhir R (2011) Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson’s disease. Neurochem Res 36:1435–1443. doi:10.1007/s11064-011-0469-3